+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acute Care Syndromic Testing Market - Global Forecast 2026-2032- Product Image
Acute Care Syndromic Testing Market - Global Forecast 2026-2032- Product Image
New

Acute Care Syndromic Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924822
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The acute care syndromic testing market is advancing rapidly as healthcare organizations prioritize faster diagnostics, seamless data integration, and operational efficiency to meet evolving clinical demands and regulatory frameworks. Decision-makers are recalibrating procurement strategies to navigate technological innovation, infection control mandates, and supply chain complexity.

Market Snapshot: Acute Care Syndromic Testing Market Overview

The Acute Care Syndromic Testing Market expanded from USD 7.44 billion in 2025 to USD 8.40 billion in 2026 and is forecast to reach USD 18.14 billion by 2032, maintaining a CAGR of 13.58%. This steady growth trajectory highlights strong adoption by hospital systems, public health laboratories, and urgent care facilities. Demand is highest where rapid and high-throughput diagnostic platforms intersect with the need for improved clinical workflow, enhanced infection control, and better allocation of healthcare resources. Syndromic testing solutions are benefiting from heightened awareness around outbreak response and real-time data needs, bolstering investments across key regions and end-user groups.

Scope & Segmentation of the Acute Care Syndromic Testing Market

This report delivers a comprehensive analysis, addressing strategic segmentation factors critical to senior decision-makers:

  • Syndrome-Specific Panels: Panels targeting central nervous system, gastrointestinal, respiratory, and sexually transmitted infections support frontline diagnosis and align with varied patient presentations and clinical priorities.
  • Product Types: Solutions include benchtop instruments, point-of-care devices, cartridgeized assays, multiplex assay kits, single-use reagents, and customizable software or service packages to meet diverse operational demands.
  • Technology Platforms: Multiplex PCR, quantitative PCR (qPCR), next-generation sequencing, microarray, and mass spectrometry facilitate panel breadth, analytical sensitivity, and rapid turnarounds for acute care settings.
  • End-User Environments: Hospital laboratories, reference centers, public health agencies, academic institutes, and decentralized outpatient clinics represent the primary points of adoption, each with unique workflow and compliance requirements.
  • Application Priorities: Focus areas include differential diagnosis, pathogen surveillance, outbreak investigation, epidemiological reporting, and integration with translational research pipelines.
  • Regional Deployment: Distinct market dynamics are present in the Americas, Europe, Middle East & Africa, and Asia-Pacific regions, with adoption patterns shaped by regulatory standards, supply infrastructure, and local partnership requirements.

Key Takeaways for Senior Decision-Makers

  • Rapid syndromic testing solutions are streamlining clinical decision-making by enabling simultaneous detection of multiple infectious agents, which enhances infection control and supports effective case management.
  • Technological advances are fostering platform interoperability and more robust sample-to-answer solutions, prompting procurement criteria to shift toward integration and flexibility.
  • Strategic planning increasingly weighs the balance between high-throughput laboratory capabilities and the need for agile point-of-care testing to address varying clinical and epidemiological scenarios.
  • Institutional buying decisions are being guided by demands for scalable assay menus, data connectivity, and adaptable service models that align with evolving regulations and patient needs.
  • Regional initiatives, such as increased public health investment in Asia-Pacific and adoption of hybrid diagnostic models in the Americas, underscore the significance of local supplier relationships and responsive supply chain strategies.

Tariff Impact on Supply and Procurement Strategies

Recent changes in tariff policies are intensifying pressures on the global syndromic diagnostic supply chain, specifically for essential components like reagents, cartridges, and instrumentation. Laboratories are responding with adaptive sourcing approaches, such as diversification and localized procurement, to protect capacity and manage costs. Manufacturers are adjusting site operations and revising contract terms, aiming to reduce tariff exposure and provide reassurance to institutional buyers. This complex environment necessitates close collaboration among procurement specialists, clinical leaders, and supply partners to maintain reliable diagnostic service.

Acute Care Syndromic Testing Market: Methodology & Data Sources

Analysis in this report is grounded in systematic literature reviews, regulatory document analysis, and interviews with laboratory directors, procurement specialists, and clinical leadership. Data points are validated by triangulating published studies, product documentation, and industry disclosures, ensuring consistency and relevance for executive audiences.

Why This Report Matters

  • Offers procurement and clinical executives clear direction when implementing rapid diagnostics aligned with shifting operational, regulatory, and clinical priorities.
  • Enables fact-based evaluation of technologies, service offerings, and supplier ecosystems in the context of tariff changes and supply chain disruptions.
  • Supports decision-making on investments in syndromic testing by clarifying supply resilience, cross-functional workflow integration, and long-term technology alignment.

Conclusion

Success in the acute care syndromic testing market depends on integrating clinical priorities, operational workflows, and robust supply chain strategies. Structured adoption and targeted investment will continue to drive improvements in patient outcomes and health system resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Acute Care Syndromic Testing Market, by Product Type
8.1. Instruments
8.1.1. Benchtop
8.1.2. Point Of Care
8.2. Kits Reagents
8.2.1. Cartridges
8.2.2. Multiplex Assay Kits
8.2.3. Reagents
8.3. Software Services
8.3.1. Data Management
8.3.2. Service Contracts
9. Acute Care Syndromic Testing Market, by Syndromic Panel
9.1. Central Nervous System
9.1.1. Encephalitis
9.1.2. Meningitis
9.2. Gastrointestinal
9.2.1. Bacterial
9.2.2. Parasitic
9.2.3. Viral
9.3. Respiratory
9.3.1. Bacterial
9.3.2. Combined
9.3.3. Viral
9.4. Sexually Transmitted Infection
9.4.1. Chlamydia Gonorrhea
9.4.2. Herpes
10. Acute Care Syndromic Testing Market, by Technology
10.1. Mass Spectrometry
10.2. Microarray
10.3. Multiplex Pcr
10.4. Ngs
10.5. Qpcr
11. Acute Care Syndromic Testing Market, by Application
11.1. Differential Diagnosis
11.2. Epidemiology
11.3. Outbreak Investigation
11.4. Research
11.5. Surveillance
12. Acute Care Syndromic Testing Market, by End User
12.1. Academic Research Institutes
12.2. Hospitals
12.3. Public Health Laboratories
12.4. Reference Laboratories
13. Acute Care Syndromic Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Acute Care Syndromic Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Acute Care Syndromic Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Acute Care Syndromic Testing Market
17. China Acute Care Syndromic Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Applied BioCode, Inc.
18.7. Becton, Dickinson and Company
18.8. Bio-Rad Laboratories, Inc.
18.9. Biocartis NV
18.10. BIOHM Health LLC
18.11. bioMérieux SA
18.12. Curetis GmbH b y OpGen, Inc
18.13. CVS Health
18.14. Danaher Corporation
18.15. DiaSorin S.p.A
18.16. Eurofins Scientific SE
18.17. F. Hoffmann-La Roche Ltd
18.18. Genetic Signatures Ltd.
18.19. Hologic Inc.
18.20. Luminex Corporation
18.21. Microbiologics, Inc.
18.22. Pfizer, Inc.
18.23. QIAGEN N.V.
18.24. QuantuMDx Group Ltd.
18.25. Seegene Inc.
18.26. Siemens Healthineers AG
18.27. Sysmex Corporation
18.28. Thermo Fisher Scientific Inc.
18.29. Werfen
List of Figures
FIGURE 1. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BENCHTOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BENCHTOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BENCHTOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DATA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DATA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SERVICE CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SERVICE CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SERVICE CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ENCEPHALITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ENCEPHALITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ENCEPHALITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MENINGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MENINGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MENINGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PARASITIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COMBINED, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COMBINED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CHLAMYDIA GONORRHEA, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CHLAMYDIA GONORRHEA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CHLAMYDIA GONORRHEA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HERPES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HERPES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HERPES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MICROARRAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MICROARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY NGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY NGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY NGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY QPCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY QPCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY QPCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DIFFERENTIAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DIFFERENTIAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY DIFFERENTIAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY EPIDEMIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY OUTBREAK INVESTIGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY OUTBREAK INVESTIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PUBLIC HEALTH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 184. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 186. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 187. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 188. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 189. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 193. EUROPE ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 210. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 211. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 212. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 213. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 214. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 215. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 216. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 217. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. AFRICA ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 234. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 237. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 238. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 239. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 240. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 241. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 242. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 243. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 244. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. ASEAN ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 250. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 251. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 252. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 253. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 254. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 255. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 256. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 257. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. GCC ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 275. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 276. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 277. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 278. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 279. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 280. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 281. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 282. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 283. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. BRICS ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 287. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 288. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 289. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-2032 (USD MILLION)
TABLE 290. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SOFTWARE SERVICES, 2018-2032 (USD MILLION)
TABLE 291. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SYNDROMIC PANEL, 2018-2032 (USD MILLION)
TABLE 292. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2032 (USD MILLION)
TABLE 293. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY GASTROINTESTINAL, 2018-2032 (USD MILLION)
TABLE 294. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY RESPIRATORY, 2018-2032 (USD MILLION)
TABLE 295. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION, 2018-2032 (USD MILLION)
TABLE 296. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 297. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. G7 ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. NATO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. NATO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 301. NATO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 302. NATO ACUTE CARE SYNDROMIC TESTING MARKET SIZE, BY KITS REAGENTS, 2018-203

Companies Mentioned

The key companies profiled in this Acute Care Syndromic Testing market report include:
  • Abbott Laboratories
  • Applied BioCode, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis NV
  • BIOHM Health LLC
  • bioMérieux SA
  • Curetis GmbH b y OpGen, Inc
  • CVS Health
  • Danaher Corporation
  • DiaSorin S.p.A
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Genetic Signatures Ltd.
  • Hologic Inc.
  • Luminex Corporation
  • Microbiologics, Inc.
  • Pfizer, Inc.
  • QIAGEN N.V.
  • QuantuMDx Group Ltd.
  • Seegene Inc.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Werfen

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.4 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.14 Billion
Compound Annual Growth Rate13.5%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Acute Care Syndromic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Syndromic Multiplex Diagnostics Market Report 2025 - Product Image

Syndromic Multiplex Diagnostics Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Syndromic Multiplex Diagnostics Market - Global Strategic Business Report - Product Image

Syndromic Multiplex Diagnostics Market - Global Strategic Business Report

  • Report
  • 274 Pages
  • Global
From
Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides - Product Image

Respiratory Infection Diagnostics Market 2025-2029 - Forecasts by Technology, Plex, Place, Product and Region, with Executive and Consultant Guides

  • Report
  • 606 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.